Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Liang, Taoa; b | Xue, Feixiaoc | Hang, Weijiana | Wen, Bina | Zhang, Qianyinga | Chen, Jiehuia | Liu, Xiaofenga; d; * | Chen, Juana; *
Affiliations: [a] Department of Biochemistry and Molecular Biology, School of Basic Medicine and the Collaborative Innovation Center for Brain Science, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China | [b] Department of Clinical laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China | [c] Department of Clinical laboratory, Xi’an No.3 Hospital, Xi’an, Shanxi, China | [d] Department of Laboratory Medicine and Gene Diagnostic Laboratory, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Correspondence: [*] Correspondence to: Juan Chen, Department of Biochemistry and Molecular Biology, School of Basic Medicine and the Collaborative Innovation Center for Brain Science, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China. E-mail: [email protected]; and Xiaofeng Liu, Department of Laboratory Medicine and Gene Diagnostic Laboratory, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, Fujian, China. E-mail: [email protected].
Abstract: Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer’s disease (AD). It is shown that apoE4 preferentially undergoes aberrant cleavage in neurons, yielding neurotoxic C-terminal-truncated apoE4 fragment. Endoplasmic reticulum (ER) stress has also been known to be involved in the pathogenesis of AD. However, little is known about the contribution of ER stress to the neurotoxicity of apoE4 fragment. In the present study, we established the neuron-specific expression human C-terminal-truncated apoE4(1–272) fragment transgenic mice and also transfected apoE4(1–272) fragment in neuroblastoma N2a cells. We found that human apoE4(1–272) fragment could trigger ER stress as evidenced by increasing the expression of ER stress markers both in vivo and in vitro. Meanwhile, the apoE4(1–272) transgenic mice presented obviously AD-like neuropathological changes, including the impairment of spatial learning and memory, prominent axonal morphological changes, and hyperphosphorylation of tau. At the same time, we also found that glycogen synthase kinase-3 activities were significantly increased. Furthermore, these neuropathological changes, especially tau hyperphosphorylation and axonal transport impairment, were significantly rescued by the ER stress protector 4-phenylbutyric acid (4-PBA) in apoE4(1–272)-transfected N2a cells. Pretreatment with 4-PBA not only decreased the protein expression of immunoglobulin binding protein (BiP) and C/EBP-homologous protein (CHOP), but also significantly reversed these defects in axonal transport. These results suggested that the neurotoxic effects of apoE4(1–272) fragment found in AD subjects, at least in part, through triggering ER stress and inducing tau hyperphosphorylation, led to the enduring impairment of axonal transport.
Keywords: Alzheimer’s disease, apolipoprotein E4 (1–272), axonopathy, endoplasmic reticulum stress, tau phosphorylation
DOI: 10.3233/JAD-190419
Journal: Journal of Alzheimer's Disease, vol. 71, no. 2, pp. 597-611, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]